Federico Grossi - Mar 15, 2022 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ David Watson, attorney-in-fact for Dr. Federico Grossi
Stock symbol
APLS
Transactions as of
Mar 15, 2022
Transactions value $
$15,331
Form type
4
Date filed
3/17/2022, 06:19 PM
Previous filing
Mar 2, 2022
Next filing
May 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Options Exercise $30.2K +7K +6.37% $4.31* 117K Mar 15, 2022 Direct
transaction APLS Common Stock Sale -$14.8K -375 -0.32% $39.57 116K Mar 15, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APLS Stock Option (Right to Buy) Options Exercise $0 -7K -12.13% $0.00 50.7K Mar 15, 2022 Common Stock 7K $4.31 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This is a scheduled sale from 10B5-1 trading plan.
F2 This stock option was granted on 08/21/2017 and is fully vested.